Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,415 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    Proportionality Requirements In Discovery

    Under the Federal Rules, discovery is limited to nonprivileged material that is both "relevant to any party's claim or defense and proportional to the needs of the case."
    United StatesLitigation, Mediation & Arbitration
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Courts And Legislators Addressing The Right Of Publicity In The Age Of AI

    The creative promise of generative artificial intelligence ("GenAI or "AI") is tremendous. Irrespective of artistic talent, any user can enter a text prompt into...
    United StatesTechnology
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    2020 Update: The UK Government Has "No Plans" To Implement The Controversial EU Copyright Directive

    Remaining member states still have until 12 June 2021 to implement the Directive into national laws.
    European UnionIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    CRISPR Patent - "Appeal Dismissed, Patent Revoked"

    On 13 January 2020, the Board of Appeal kicked off the much awaited CRISPR hearing. After a long battle, on 16 January 2020...
    European UnionIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Latest Update: Publication Of The New EU Copyright Directive And Discussion On Implementation

    On April 15, the Council of the EU approved the new Directive on Copyright in the Digital Single Market (now titled Directive 2017/790). The Directive has a clear objective, to modernise the legislative framework
    European UnionIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    The EPO's "10 Day Notification Period" Comes To An End

    From 1 November 2023, the "10 day notification period" historically provided by the EPO for communications and many associated deadlines will no longer apply.
    European UnionIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    UK Ratifies Hague Agreement For Industrial Designs

    On 13th March 2018, the UK deposited the instrument of ratification of the Geneva Act (1999) of the Hague Agreement with WIPO, in Geneva, completing its final step toward joining the Hague Agreement ...
    European UnionIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Update From The EPO On Opposition Oral Proceedings

    Earlier this year, the EPO announced a pilot scheme for Opposition Division Oral Proceedings via videoconference.
    European UnionIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Update On The UPC – Implementation Of Case Management System (CMS) Is Making Progress

    As previously reported, the Unified Patent Court's Administrative Committee adopted the Rules of Procedure (RoP) for litigation in the Unified Patent Court (UPC) on 8 July 2022.
    European UnionIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Remarks On The Decision "Liquid Supply Devices" Of The German Court Of Justice

    The assessment of inventive step from a German view requires that the person skilled in the art not only has a motivation to modify or adapt the relevant prior art, but also that there is an appropriate suggestion.
    GermanyIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Remarks On The Decision ‘Duty To Digitalize For Rendering Information And Accounts'

    If a patent owner wants to claim damages from an infringer, he bears the burden of proof for the facts substantiating the amount to be claimed.
    GermanyIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    A Battle Of What "A PH Of 13 Or Higher" Means

    Finnegan attorney Chiaki Kobayashi authored an article titled, "A battle of what ‘a pH of 13 or higher' means" for the August 2024 issue of Intellectual Property Management...
    GlobalIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Changes In UK Official Patent Fees Part 2 - Consequences Of Non-Payment

    As previously reported here, on 6 April 2018 the UK Intellectual Property Office (UKIPO) introduced a number of changes to official fees for UK patent applications.
    United KingdomIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Life Sciences Podcast Series - Patent Applications Based On Clinical Trials

    The Life Sciences industry can be particularly challenging for companies to navigate, often requiring careful navigation through rigorous testing and regulatory compliance.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Myriad, Mayo, Chakrabarty, Oh My: Strategies For Life Sciences Diagnostics - Part I

    Patent eligibility is a balancing act; the Supreme Court explained in Mayo that "too broad an interpretation of this exclusionary principle could eviscerate patent law
    United StatesFood, Drugs, Healthcare, Life Sciences
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Podcast: Life Sciences Podcast Series - Inventorship

    The Life Sciences industry can be particularly challenging for companies to navigate, often requiring careful navigation through rigorous testing and regulatory compliance.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    SaMD Series: Branding Considerations

    Software as a Medical Device–also referred to as SaMD–is one of the fastest growing innovations in the medical device industry
    United StatesFood, Drugs, Healthcare, Life Sciences
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Podcast

    10 Years Later: Reflecting On The America Invents Act (Podcast)

    In honor of the 10-year anniversary of the America Invents Act (AIA), Finnegan partners Arpita Bhattacharyya and Tim McAnulty...
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Affirmed Preliminary Injunction Leaves Water Balloon Infringer All Wet

    In Tinnus Enterprises, LLC v. Telebrands Corp., No. 16-1410 (Fed. Cir. Jan. 24, 2017), the Federal Circuit affirmed the district court's grant of a preliminary injunction, finding no clear error in that decision.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Anti-SLAPP Confers Jurisdiction For Interlocutory Appeals

    In IQE PLC. v. Newport Fab, LLC, No. 2024-1124 (Fed. Cir. Oct. 15, 2025), the Federal Circuit vacated a district court decision denying defendant's Anti-SLAPP motion.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Showing 781–800 of 4415 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics